about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumMolecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapyPolymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of IndiaDomestic trends in malaria research and development in China and its global influenceThe Plasmodium falciparum malaria M1 alanyl aminopeptidase (PfA-M1): insights of catalytic mechanism and function from MD simulationsAntimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasitesTheoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparumAmeliorative Effects of Curcumin on Artesunate-Induced Subchronic Toxicity in Testis of Swiss Albino Male MiceCan pharmacogenomics improve malaria drug policy?Managing malaria in the intensive care unit.Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan childrenCost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.Cyclopropyl carboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screen.Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malariaMK-4815, a potential new oral agent for treatment of malariaSubacute therapeutic dosing of artemether-lumefantrine and artesunate-amodiaquine combination preserves plasma cholesterol, renal antioxidant status, and organ weights in rats.Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocolTherapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border.Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialExploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic targetAnti-malarial activity of indole alkaloids isolated from Aspidosperma olivaceum.Artemisinin derivatives: a patent review (2006 - present).Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC.In vitro sensitivity to antimalarial drugs and polymorphisms in Pfg377 gene in Plasmodium falciparum field isolates from Mewat, India.Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.Household beliefs about malaria testing and treatment in Western Kenya: the role of health worker adherence to malaria test resultsGeographical origin of post-landmine injury malaria infections.Tagging to endogenous genes of Plasmodium falciparum using CRISPR/Cas9.Artemisinin combination therapies and malaria parasite drug resistance: the game is afoot.Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.Adherence to treatment with artemether-lumefantrine or amodiaquine-artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial.
P2860
Q21032477-0B6291CB-3DA7-4CF2-B676-6480C9F2918DQ28125911-BF915C34-D7E5-4AEF-8D24-A1809B34F355Q28125924-4764F4B6-0A42-4713-B539-8DB5E9F56C6EQ28365208-345A82A1-941A-497B-B0AE-AFA55DFDC140Q28478520-0F492969-7C62-4D26-8094-73D7E0CEA872Q28483905-731D118A-E4AC-4676-BC43-A1438518096EQ28541220-F381A071-0D73-4698-B611-2FBE86750DA6Q28551461-FC9084D5-B002-408C-9DE4-3B65C7FE0EC1Q34029396-419C83D2-8D0F-4D85-BDE9-BBA4F18FB2BAQ34532597-1CD82F1B-E5E0-4712-AB76-74101628A17AQ34562333-8096302B-7181-41F8-A297-F2BB1ED2198CQ34600201-7A1D6209-DB16-4120-B536-F14694C5EEB2Q35101269-0DFED28B-331A-425F-8A16-AA9CE579406BQ35186886-81F8EA75-69B3-4DD8-B2FF-FF58BE9F2683Q35598598-22C18A23-369A-4A7D-80E6-367DDDDBFF33Q35666544-9A76501E-8C5E-4E5A-8682-47FAEA91A528Q35941421-E01BB0AB-94C6-42E8-A241-E75E444BF378Q36104479-87EC9F7E-6B80-4693-B17B-64DC0C58F195Q36232163-DF2E32CD-E5DC-4DF6-B29B-34535E605AD2Q36380302-19D060CF-361F-4044-A7AE-8602B1E826B8Q36427654-0A5B735D-AF7A-4727-95D7-EAFC4C5243B5Q37668206-F1A581ED-6163-4592-99FF-53B3DD126AC9Q37735078-0A4250AF-8CD0-4035-954F-B5094CF61D42Q38042732-5DB14041-33A3-4C25-A014-0224B0B51F2DQ39420155-CB7B5612-9EC0-4770-8265-D19C5A6FA7C6Q40175988-DDB3B231-41DA-4BAB-B2AA-9E9A3E3314A4Q40981118-9FB8A774-853B-4E65-B872-E8CE13669B07Q41498158-6A86F275-0C37-4AFC-B3FE-19F98477CA0AQ41711245-945CA8A9-274D-4677-A156-6EF08EAF3DBBQ47130805-8F5A8EF1-ED5D-4F47-8A62-1CC75061A743Q47859200-3C6486FA-1A88-4956-9212-C94BC5E0624DQ47864660-62ED27F3-B4C1-4FE7-A3C8-83A276617CE6Q55491745-70143C4D-C334-4300-9A5B-A01565687BB0
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Drug-Resistant Malaria: The Era of ACT.
@ast
Drug-Resistant Malaria: The Era of ACT.
@en
Drug-Resistant Malaria: The Era of ACT.
@nl
type
label
Drug-Resistant Malaria: The Era of ACT.
@ast
Drug-Resistant Malaria: The Era of ACT.
@en
Drug-Resistant Malaria: The Era of ACT.
@nl
prefLabel
Drug-Resistant Malaria: The Era of ACT.
@ast
Drug-Resistant Malaria: The Era of ACT.
@en
Drug-Resistant Malaria: The Era of ACT.
@nl
P2093
P2860
P1476
Drug-Resistant Malaria: The Era of ACT.
@en
P2093
Chansuda Wongsrichanalai
Jessica T Lin
Jonathan J Juliano
P2860
P304
P356
10.1007/S11908-010-0099-Y
P577
2010-05-01T00:00:00Z